State Stem Cell Agency Facilities Working Group Agenda 03-09-09

Mar 9, 2009
Main Location: 

CIRM
210 King Street
3rd Floor
San Francisco, CA 94107

 

 

 

 

 

 

 

 

 

California State Stem Cell Agency

 

MEETING NOTICE AND AGENDA 03-09-09

ANNUAL MEETING OF THE
SCIENTIFIC AND MEDICAL RESEARCH FACILITIES WORKING GROUP
(FACILITIES WORKING GROUP)
OF THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 

OPEN SESSION

  1. Call to Order
  2. Roll Call
  3. Welcome and Introductions
  4. Status Update on Major Facilities Projects.
       a. Video Presentation of CIRM Major Facilities Speed Science and Create Jobs
       b. Staff Report on Status of Shared Facilities
       c. Staff Report on Status of Major Facilities Awards
       d. Consideration of Modification to Merced Major Facilities Award
  5. Discussion of CIRM GMP Report and Recommendations. PowerPoint presentation
  6. Public Comment.   Members of the public will be invited to provide testimony. Speakers are asked to limit their testimony to three (3) minutes.
  7. Adjournment.

Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 


 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at (415) 396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Scientific & Medical Research Facilities Working Group meeting may be referred to Pat Beaupre Becker at the California Institute for Regenerative Medicine at pbecker@cirm.ca.gov or (415) 396-9105.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at www.cirm.ca.gov.

 

Transcripts: 

© 2013 California Institute for Regenerative Medicine